Cutera, Inc. (CUTR) Position Boosted by Russell Investments Group Ltd.
Russell Investments Group Ltd. boosted its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 55.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 171,515 shares of the medical device company’s stock after acquiring an additional 60,986 shares during the period. Russell Investments Group Ltd. owned 1.22% of Cutera worth $7,093,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of CUTR. Renaissance Technologies LLC lifted its position in Cutera by 0.8% during the second quarter. Renaissance Technologies LLC now owns 1,214,500 shares of the medical device company’s stock valued at $31,456,000 after purchasing an additional 9,100 shares during the last quarter. Gamco Investors INC. ET AL lifted its position in Cutera by 3.7% during the second quarter. Gamco Investors INC. ET AL now owns 576,363 shares of the medical device company’s stock valued at $14,928,000 after purchasing an additional 20,363 shares during the last quarter. Vanguard Group Inc. lifted its position in Cutera by 3.4% during the second quarter. Vanguard Group Inc. now owns 570,948 shares of the medical device company’s stock valued at $14,788,000 after purchasing an additional 18,549 shares during the last quarter. Kennedy Capital Management Inc. bought a new stake in Cutera during the second quarter valued at approximately $9,426,000. Finally, Teton Advisors Inc. lifted its position in Cutera by 6.7% during the second quarter. Teton Advisors Inc. now owns 319,000 shares of the medical device company’s stock valued at $8,262,000 after purchasing an additional 20,000 shares during the last quarter. 87.64% of the stock is owned by institutional investors.
Shares of Cutera, Inc. (NASDAQ:CUTR) opened at $44.55 on Friday. The firm has a market cap of $547.27, a P/E ratio of 50.64, a PEG ratio of 1.71 and a beta of 0.53. Cutera, Inc. has a 1-year low of $16.55 and a 1-year high of $47.15.
Cutera (NASDAQ:CUTR) last announced its quarterly earnings data on Tuesday, November 7th. The medical device company reported $0.42 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.08 by $0.34. The firm had revenue of $38.17 million during the quarter, compared to analyst estimates of $34.82 million. Cutera had a net margin of 7.99% and a return on equity of 18.73%. The business’s quarterly revenue was up 26.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.12 EPS. equities analysts forecast that Cutera, Inc. will post 0.55 EPS for the current year.
Several brokerages have issued reports on CUTR. BidaskClub upgraded shares of Cutera from a “hold” rating to a “buy” rating in a research report on Saturday, August 12th. TheStreet upgraded shares of Cutera from a “c” rating to a “b” rating in a research report on Friday, August 18th. Maxim Group lowered shares of Cutera from a “buy” rating to a “hold” rating in a report on Thursday, September 14th. Zacks Investment Research lowered shares of Cutera from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Finally, Roth Capital boosted their price objective on shares of Cutera from $41.00 to $47.00 and gave the stock a “buy” rating in a report on Tuesday, September 12th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $37.33.
In related news, Director Timothy J. Oshea sold 4,000 shares of the company’s stock in a transaction on Monday, October 16th. The shares were sold at an average price of $39.21, for a total transaction of $156,840.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Larry Laber sold 1,250 shares of the company’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $44.30, for a total transaction of $55,375.00. Following the sale, the executive vice president now owns 70,463 shares of the company’s stock, valued at $3,121,510.90. The disclosure for this sale can be found here. Insiders have sold a total of 20,725 shares of company stock valued at $843,253 over the last quarter. 11.60% of the stock is currently owned by company insiders.
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.